Suzanne Louise Bruhn - Sep 30, 2021 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Christopher R. Sullivan, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Sep 30, 2021
Transactions value $
$0
Form type
4
Date filed
10/4/2021, 04:48 PM
Previous filing
Jul 2, 2021
Next filing
Nov 12, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +5.2K $0.00 5.2K Sep 30, 2021 Common Stock 5.2K $2.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of this stock option will immediately vest on the date that it is granted.